Genetic deletion of GPR68 in mice or pharmacologic inhibition reduces colitis severity and diminishes inflammatory cytokines, chemokines, and collagen deposition, indicating that GPR68 contributes to macrophage recruitment, fibroblast activation, and tissue fibrosis under chronic inflammatory and acidic conditions [37,38,39]. Here, GPR68 is linked to colitis.